There has been sweeping legislation impacting the Life Science industry, including manufacturers and distributors of pharmaceuticals, medical devices, and other healthcare related businesses. This webinar will discuss these new laws providing insight about what the immunities are, what they are not, who is covered, the positive elements of the legislation, and potential exceptions. Additionally, there will be key takeaways and suggestions about what businesses can do to prepare.
News & Insights
The COVID-19 Impact on Life Science Product Liability & Underwriting
Discussing the federal government’s response to the COVID-19 pandemic and its effect on product liability insurance